S H Bonakdaran1, M Khajeh-Dalouie. 1. Endocrine Research Center, Mashhad University of Medical Sciences, Iran. bonakdaransh@mums.ac.ir
Abstract
OBJECTIVE: Safety of fasting in Ramadan for diabetic patients is not clearly known. The aim of this study was to determine the effects of fasting on glycemic excursions by continuous glucose monitoring system (CGMS). MATERIALS AND METHODS: This pilot, observational study conducted in the Endocrine Research Center, Mashhad University of Medical Sciences, Mashhad, IRAN, in Ramadan 2008. Seventeen well controlled patients with diabetes type 2 who were taking oral agents underwent 72 hour monitoring of glycemic excursions by CGMS one month before Ramadan and during Ramadan. The extent and duration of hyperglycemic and hypoglycemic events were evaluated and compared. RESULTS: A significant reduction in hyperglycemic events was observed during Ramadan. The extent and duration of hypoglycemic events was not significantly different between two states (Ramadan and before). A significant increase in number of hypoglycemic events in Ramadan was found in patients who take sulfonylurea compared with those who take only metformin. CONCLUSION: Fasting in Ramadan can be safe for well controlled patients with type 2 diabetes.
OBJECTIVE: Safety of fasting in Ramadan for diabeticpatients is not clearly known. The aim of this study was to determine the effects of fasting on glycemic excursions by continuous glucose monitoring system (CGMS). MATERIALS AND METHODS: This pilot, observational study conducted in the Endocrine Research Center, Mashhad University of Medical Sciences, Mashhad, IRAN, in Ramadan 2008. Seventeen well controlled patients with diabetes type 2 who were taking oral agents underwent 72 hour monitoring of glycemic excursions by CGMS one month before Ramadan and during Ramadan. The extent and duration of hyperglycemic and hypoglycemic events were evaluated and compared. RESULTS: A significant reduction in hyperglycemic events was observed during Ramadan. The extent and duration of hypoglycemic events was not significantly different between two states (Ramadan and before). A significant increase in number of hypoglycemic events in Ramadan was found in patients who take sulfonylurea compared with those who take only metformin. CONCLUSION: Fasting in Ramadan can be safe for well controlled patients with type 2 diabetes.
Authors: Syed H Ahmed; Tahseen A Chowdhury; Sufyan Hussain; Ateeq Syed; Ali Karamat; Ahmed Helmy; Salman Waqar; Samina Ali; Ammarah Dabhad; Susan T Seal; Anna Hodgkinson; Shazli Azmi; Nazim Ghouri Journal: Diabetes Ther Date: 2020-09-09 Impact factor: 2.945
Authors: Melanie Yee Lee Siaw; Daniel Ek Kwang Chew; Rinkoo Dalan; Shaikh Abdul Kader Kamaldeen Abdul Shakoor; Noorani Othman; Chor Hui Choo; Nur Hidayah Shamsuri; Siti Nurhana Abdul Karim; Sui Yung Chan; Joyce Yu-Chia Lee Journal: Int J Endocrinol Date: 2014-11-11 Impact factor: 3.257
Authors: Dana Abdelrahim; MoezAlIslam E Faris; Mohamed Hassanein; Ayman Z Shakir; Ayesha M Yusuf; Aljohara S Almeneessier; Ahmed S BaHammam Journal: Front Endocrinol (Lausanne) Date: 2021-03-08 Impact factor: 5.555
Authors: Mohamed H Ahmed; Nazik Elmalaika Husain; Wadie M Elmadhoun; Sufian K Noor; Abbas A Khalil; Ahmed O Almobarak Journal: J Family Med Prim Care Date: 2017 Jan-Mar